レムデシビルの世界市場レポート 2024年

レムデシビルの市場規模は、今後数年間で急激に成長すると予想されます。 2028年には21.4%の年間複合成長率（CAGR）で141億2,000万米ドルに成長すると予想されます。今後の期間に予想される成長は、新型コロナウイルスCOVID-19への対応における継続的な取り組み、新たな変異種に関連する懸念、広範な世界のワクチン接種キャンペーン、将来のパンデミックへの備え、世界の健康への取り組みへの継続的な注力など、いくつかの重要な要因と関連しています。

政府支出の増加により、レムデシビル市場の拡大が促進されると予想されます。政府が運営、プログラム、サービスに向けた資金を含むこの形態の支出は、特に公衆衛生上の危機の際に、レムデシビルのアクセスしやすさと成長を促進する上で極めて重要な役割を果たします。政府は、資源を割り当て、規制上の支援を提供し、調査に投資することにより、この重要な抗ウイルス薬の入手可能性と手頃な価格の向上に大きく貢献しています。たとえば、2023年 7月に英国政府はサービスと資本プロジェクトへの支出を増加し、それによって市場の成長に貢献しました。

臨床試験や研究に対する需要が高まり、レムデシビル市場を刺激する態勢が整っています。医療におけるこれらの体系的な調査では、COVID-19感染症のようなウイルス感染症の治療におけるレムデシビルの有効性など、医療介入の安全性と有効性が評価されています。これらの試験では、症状の重症度、期間、安全性に対する薬剤の影響に関する重要な科学的証拠が得られます。たとえば、2023年 5月の時点で、登録された臨床研究の増加は顕著であり、研究と治験の必要性が高まっていることを示しています。この需要の急増は、市場の成長の原動力であることを強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のレムデシビル市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のレムデシビル市場規模実績と成長、2018～2023年
• 世界のレムデシビル市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のレムデシビル市場、剤形別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 錠剤
• 凍結溶液
• 凍結乾燥溶液
• 世界のレムデシビル市場、投与経路別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 経口
• 静脈内
• 世界のレムデシビル市場、流通チャネル別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• クリニック
• ドラッグストア・薬局
• オンライン
• その他

第7章 地域と国の分析

• 世界のレムデシビル市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のレムデシビル市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• レムデシビル市場の競合情勢
• レムデシビル市場の企業プロファイル
  • Gilead Sciences Inc.
  • BrightGene Bio-Medical Technology Co Ltd
  • Hainan Hayao Co. Ltd.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Hunan Warrant Pharmaceutical

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

Remdesivir, classified as an antiviral drug, is utilized in the treatment of hospitalized adults and children aged 28 days and older, weighing at least 6.6 pounds, for the management of COVID-19 disease 2019 (COVID-19) caused by the SARS-CoV-2 virus. It is specifically recommended for individuals at significant risk of developing severe COVID-19, potentially leading to hospitalization or fatal outcomes.

The primary routes of administering remdesivir are oral and intravenous. Intravenous administration involves delivering the drug or substance directly into a vein using a syringe or tubing. Remdesivir is available in various dosage forms such as tablets, frozen solutions, and lyophilized solutions. These medications are distributed through diverse channels including hospitals, clinics, drug stores or pharmacies, online platforms, and other relevant healthcare avenues.

The remdesivir market research report is one of a series of new reports from The Business Research Company that provides remdesivir market statistics, including remdesivir industry global market size, regional shares, competitors with a remdesivir market share, detailed remdesivir market segments, market trends and opportunities, and any further data you may need to thrive in the remdesivir industry. This Remdesivir market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The remdesivir market size has grown exponentially in recent years. It will grow from $4.95 billion in 2023 to $6.49 billion in 2024 at a compound annual growth rate (CAGR) of 31.2%. Historical growth in the utilization and recognition of remdesivir can be primarily attributed to several key factors. These include the escalating prevalence of COVID-19, heightened awareness regarding the drug remdesivir, substantial government support directed towards its usage, extensive clinical trials and research initiatives exploring its efficacy, and significant government procurement efforts to acquire and distribute the medication. These elements collectively contributed to the growth observed in the past period within the domain of remdesivir.

The remdesivir market size is expected to see exponentially grown in the next few years. It will grow to $14.12 billion in 2028 at a compound annual growth rate (CAGR) of 21.4%. Anticipated growth in the upcoming period is linked to several key factors, including sustained efforts in responding to COVID-19, concerns related to emerging variants, widespread global vaccination campaigns, readiness for future pandemics, and a continued focus on global health initiatives.

Rising government expenditure is anticipated to drive the expansion of the remdesivir market. This form of spending, encompassing funds directed by the government toward operations, programs, and services, plays a pivotal role in fostering the accessibility and growth of Remdesivir, particularly in times of public health crises. By allocating resources, providing regulatory support, and investing in research, governments contribute significantly to enhancing the availability and affordability of this critical antiviral medication. For instance, in July 2023, the UK government increased its spending on services and capital projects, thereby contributing to the market's growth.

The escalating demand for clinical trials and research is poised to fuel the remdesivir market. These systematic investigations in healthcare evaluate the safety and efficacy of medical interventions, including Remdesivir's effectiveness in treating viral infections like COVID-19. These trials yield vital scientific evidence regarding the drug's impact on symptom severity, duration, and safety. For instance, as of May 2023, there has been a notable increase in registered clinical studies, indicating a growing need for research and trials. This surge in demand underscores the driving force behind the market's growth.

Major companies in the remdesivir market are obtaining FDA approvals for new drugs, such as Veklury (Remdesivir), to bolster their market position. Veklury, approved by the FDA in January 2022, serves as an antiviral medication specifically designed to treat mild to moderate COVID-19 symptoms in adults and children. This strategic move by companies like Gilead Sciences Inc. contributes to their profitability and market dominance.

Strategic partnerships among key market players are fostering profitability within the remdesivir market. For example, In 2021, Gilead Sciences Inc., in a collaboration with the Center for Translational Antiviral Research, aims to explore an oral modification of remdesivir. This partnership seeks to develop an oral form of the drug for home consumption, promising a significant advancement in COVID-19 treatment. Such collaborations underline efforts to innovate and create effective antiviral medications for various diseases, emphasizing the market's growth potential.

In February 2023, Kite Pharma, a US-based biotechnology firm, completed the acquisition of Tmunity Therapeutics Inc for an undisclosed sum. This strategic move is aimed at granting Kite access to a range of pre-clinical and clinical initiatives, as well as efficient production techniques. Notably, the acquisition includes access to Tmunity's 'armored' CAR T technology platform, which holds promise for enhancing the effectiveness of various CAR T therapies against tumors.

Major companies operating in the remdesivir market include Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd., Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Pfizer Inc., Merck & Co. Inc., Cayman Chemical Company, Dr Reddy's Laboratories Ltd., Inovio Pharmaceuticals, Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Berry Global Group, Hetero Labs Limited, Mylan N.V., Jubilant Generics, Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories

North America was the largest region in the remdesivir market in 2023. Middle East is expected to be the fastest growing region in the remdesivir market report during the forecast period. The regions covered in the remdesivir market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the remdesivir market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The remdesivir market consists of sales of nucleotide analogue and Veklury. Values in this market are 'factory gate values,' that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Remdesivir Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on remdesivir market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for remdesivir? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The remdesivir market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Route Of Administration: Oral; Intravenous
• 2) By Dosage Form: Tablets; Frozen Solution; Lyophilized Solution
• 3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Other Distribution Channels
• Companies Mentioned: Gilead Sciences Inc.; BrightGene Bio-Medical Technology Co Ltd; Hainan Haiyao Co. Ltd.; Sichuan Kelun Pharmaceutical Co. Ltd.; Hunan Warrant Pharmaceutical
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Remdesivir Market Characteristics

3. Remdesivir Market Trends And Strategies

4. Remdesivir Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Remdesivir Market Size and Growth

• 5.1. Global Remdesivir Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Remdesivir Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Remdesivir Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Remdesivir Market Segmentation

• 6.1. Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tablets
• Frozen Solution
• Lyophilized Solution
• 6.2. Global Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Intravenous
• 6.3. Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Drug Stores/Pharmacies
• Online
• Other Distribution Channels

7. Remdesivir Market Regional And Country Analysis

• 7.1. Global Remdesivir Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Remdesivir Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Remdesivir Market

• 8.1. Asia-Pacific Remdesivir Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Remdesivir Market

• 9.1. China Remdesivir Market Overview
• 9.2. China Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Remdesivir Market

• 10.1. India Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Remdesivir Market

• 11.1. Japan Remdesivir Market Overview
• 11.2. Japan Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Remdesivir Market

• 12.1. Australia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Remdesivir Market

• 13.1. Indonesia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Remdesivir Market

• 14.1. South Korea Remdesivir Market Overview
• 14.2. South Korea Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Remdesivir Market

• 15.1. Western Europe Remdesivir Market Overview
• 15.2. Western Europe Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Remdesivir Market

• 16.1. UK Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Remdesivir Market

• 17.1. Germany Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Remdesivir Market

• 18.1. France Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Remdesivir Market

• 19.1. Italy Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Remdesivir Market

• 20.1. Spain Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Remdesivir Market

• 21.1. Eastern Europe Remdesivir Market Overview
• 21.2. Eastern Europe Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Remdesivir Market

• 22.1. Russia Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Remdesivir Market

• 23.1. North America Remdesivir Market Overview
• 23.2. North America Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Remdesivir Market

• 24.1. USA Remdesivir Market Overview
• 24.2. USA Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Remdesivir Market

• 25.1. Canada Remdesivir Market Overview
• 25.2. Canada Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Remdesivir Market

• 26.1. South America Remdesivir Market Overview
• 26.2. South America Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Remdesivir Market

• 27.1. Brazil Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Remdesivir Market

• 28.1. Middle East Remdesivir Market Overview
• 28.2. Middle East Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Remdesivir Market

• 29.1. Africa Remdesivir Market Overview
• 29.2. Africa Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Remdesivir Market Competitive Landscape And Company Profiles

• 30.1. Remdesivir Market Competitive Landscape
• 30.2. Remdesivir Market Company Profiles
  • 30.2.1. Gilead Sciences Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. BrightGene Bio-Medical Technology Co Ltd
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Hainan Hayao Co. Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sichuan Kelun Pharmaceutical Co. Ltd.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Hunan Warrant Pharmaceutical
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Remdesivir Market Competitive Benchmarking

32. Global Remdesivir Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Remdesivir Market

34. Remdesivir Market Future Outlook and Potential Analysis

• 34.1 Remdesivir Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Remdesivir Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Remdesivir Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer